Synonyms: CDRI-80/53 | elubaquine
Compound class:
Synthetic organic
Comment: Bulaquine is an 8-aminoquinoline derivative that has antimalarial activity and is a synthetic analogue of primaquine.
The INN record for bulaquine indicates that it is a racemic mixture. The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. |
|
Guide to Malaria Pharmacology Comments |
Bulaquine was developed by the Central Drug Research Institute (CDRI) in the early 1980s as a potential antimalarial therapy for use in the prevention of relapse of P. vivax malaria. Potential Target/Mechanism Of Action: As the precise mechanism of action of bulaquine is not yet known, we do not have a molecular target for this compound. |